Related content

Agreement between self-reported use of in vitro fertilization or ovulation induction, and medical insurance claims in Australian women aged 28–36 years

By Herbert Danielle   Lucke Jayne   Dobson Annette  

Human Reproduction, Vol. 27, Iss. 9, 2012-09 ,pp. : 2823-2828

Oxford University Press

Access to resources Recommend Favorite

Predictive value of the results of a first in-vitro fertilization cycle on the outcome of subsequent cycles

By Croucher CA   Lass A   Margara R   Winston RM  

Human Reproduction, Vol. 13, Iss. 2, 1998-02 ,pp. : 403-408

Oxford University Press

Access to resources Recommend Favorite

Monitoring stimulated cycles during in vitro fertilization treatment with ultrasound only – preliminary results

By Wiser Amir   Gonen Ofer   Ghetler Yehudit   Shavit Tal   Berkovitz Arie   Shulman Adrian  

Gynecological Endocrinology, Vol. 28, Iss. 6, 2012-06 ,pp. : 429-431

Informa Healthcare

Access to resources Recommend Favorite

Oocyte morphological abnormalities in overweight women undergoing in vitro fertilization cycles

By Depalo Raffaella   Garruti Gabriella   Totaro Ilaria   Panzarino Mariantonietta   Vacca Margherita Patrizia   Giorgino Francesco   Selvaggi Luigi Eustacchio  

Gynecological Endocrinology, Vol. 27, Iss. 11, 2011-11 ,pp. : 880-884

Informa Healthcare

Access to resources Recommend Favorite

Anti-Müllerian hormone levels and antral follicle count in women enrolled in in vitro fertilization cycles: Relationship to lifestyle factors, chronological age and reproductive history

By Nardo Luciano   Christodoulou Dimitra   Gould Della   Roberts Steve   Fitzgerald Cheryl   Laing Ian  

Gynecological Endocrinology, Vol. 23, Iss. 8, 2007-08 ,pp. : 486-493

Informa Healthcare

Access to resources Recommend Favorite